Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a Cohort
The first families with LRRK2 related Parkinson’s disease (PD) were presented around 15 years ago and numerous papers have described the characteristics of the LRRK2 phenotype. The prevalence of autosomal dominant PD varies around the world mainly depending on local founder effects. The highest prev...
Main Author: | Jan O. Aasly |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2021.634666/full |
Similar Items
-
Elevated Levels of Cerebrospinal Fluid α-Synuclein Oligomers in Healthy Asymptomatic LRRK2 Mutation Carriers
by: Jan eAasly, et al.
Published: (2014-09-01) -
Clinical and Imaging Markers of Prodromal Parkinson's Disease
by: Eldbjørg Hustad, et al.
Published: (2020-05-01) -
Generalized dystonia without Parkinsonism in an LRRK2 carrier
by: Lola Díaz-Feliz, et al.
Published: (2022-01-01) -
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
by: Nour K. Majbour, et al.
Published: (2020-05-01) -
LRRK2 and Proteostasis in Parkinson’s Disease
by: María Dolores Pérez-Carrión, et al.
Published: (2022-06-01)